Sevion Therapeutics COO Gregory Williams' 2019 pay falls 55% to $2.7M
Sevion Therapeutics reports 2019 executive compensation
By ExecPay News
Published: April 1, 2020
Sevion Therapeutics reported fiscal year 2019 executive compensation information on April 1, 2020.
In 2019, four executives at Sevion Therapeutics received on average a compensation package of $2.1M, a 29% decrease compared to previous year.
Average pay of disclosed executives at Sevion Therapeutics
Gregory Williams, Chief Operating Officer, received $2.7M in total, which decreased by 55% compared to 2018. 65% of Williams' compensation, or $1.8M, was in option awards. Williams also received $165K in non-equity incentive plan, $409K in salary, $346K in stock awards, as well as $12K in other compensation.
Robert E. Ward, Chief Executive Officer, received a compensation package of $2.5M, which increased by 179% compared to previous year. 70% of the compensation package, or $1.8M, was in option awards.
David P. Snow, Chief Business Officer, earned $1.9M in 2019, a 54% decrease compared to previous year.
Gregory Weaver, Chief Financial Officer, received $1.2M in 2019, which increases by 125% compared to 2018.
Related executives
You may also like
Source: SEC filing on April 1, 2020.